Outcome of adolescent patients with acute lymphoblastic leukaemia aged 10 –14 years as compared with those aged 15–17 years: Long-term results of 1094 patients of the AIEOP-BFM ALL 2000 study

Further prospective studies and biological investigations are required to define optimal treatment for adolescents, in particular for those aged 15 –17 years. Newer agents (immunotherapy, targeted therapy) in early treatment phases of patients at higher risk of treatment failure could replace most toxic treatment elements, with the aim of reducing both toxicity and the risk of relapses.

Source: European Journal of Cancer - October 17, 2019 Category: Cancer & Oncology Authors: Anna Maria Testi, Andishe Attarbaschi, Maria Grazia Valsecchi, Anja M öricke, Gunnar Cario, Felix Niggli, Daniela Silvestri, Peter Bader, Michaela Kuhlen, Rosanna Parasole, Maria Caterina Putti, Peter Lang, Christian Flotho, Georg Mann, Carmelo Rizzari, Tags: Original Research Source Type: research